Janssen/AbbVie drug approved in graft-versus-host diseaseFirst use for Imbruvica outside blood cancer. Share XJanssen/AbbVie drug approved in graft-versus-host diseasehttps://pharmaphorum.com/news/imbruvica-drug-approved-graft-versus-host-disease/
Imbruvica granted fourth Breakthrough statusThe drug is also granted Orphan Drug Designation by the FDA. Share XImbruvica granted fourth Breakthrough statushttps://pharmaphorum.com/news/abbvies-imbruvica-granted-breakthrough-therapy-designation-cgvhd/